These results suggest that MCU-KO does not eliminate the tumorigenic potential of transformed fibroblasts, whereas it markedly slows tumor growth primarily by strongly reducing cell proliferation with lesser enhancement of cell death. The gene discussed is MCU; the disease is neoplasm.